Natco Pharma Limited — Others, 06-07-2026: Change in Management

We would like to inform you that in accordance with the provisions of Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the below mentioned officials of the Company has been designated as follows w.e.f. 6th July, 2026: 1. Mr. Gnanadeva Chalapathy Gudipati has been designated as Senior Vice President - Analytical Research & Development; andMr. Madhava Rao Karicherla has been designated as Vice President Formulation Research & Development, Pharma Division, Kothur Unit